UK markets closed
NIKKEI 225
38,837.46 -85.54 (-0.22%) HANG SENG
18,444.11 +41.11 (+0.22%) CRUDE OIL
73.61 -0.61 (-0.82%) GOLD FUTURES
2,349.80 -19.50 (-0.82%) DOW
38,656.26 +85.23 (+0.22%) Bitcoin GBP
55,127.91 +965.74 (+1.78%)
CryoLife, Inc. (CYL.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:01AM CEST. Market open.
| Previous close | 21.75 |
| Open | 21.50 |
| Bid | 21.20 x 180000 |
| Ask | 21.35 x 180000 |
| Day's range | 21.50 - 21.50 |
| 52-week range | 11.70 - 22.05 |
| Volume | |
| Avg. volume | 6 |
| Market cap | 897.29M |
| Beta (5Y monthly) | 1.66 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.22 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 09 Dec 2015 |
| 1y target est | 34.19 |
ZacksArtivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Simply Wall St.Shareholders Will Probably Hold Off On Increasing Artivion, Inc.'s (NYSE:AORT) CEO Compensation For The Time Being
Key Insights Artivion will host its Annual General Meeting on 14th of May CEO Pat Mackin's total compensation includes...
PR NewswireArtivion Reports First Quarter 2024 Financial Results
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the first quarter ended March 31, 2024.
© 2024 Yahoo. All rights reserved.